Persevere Therapeutics is a clinical-stage pharmaceutical company that develops novel therapeutics for effective cancer treatments.
Persevere Therapeutics has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Persevere Therapeutics is headquartered in Berwyn, United States.
Persevere Therapeutics is a clinical-stage pharmaceutical company that develops novel therapeutics for effective cancer treatments.
Persevere Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Persevere Therapeutics — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/persevere-therapeutics. Accessed August 16, 2026.
VCBacked. (2026). Persevere Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/persevere-therapeutics
{{cite web |title=Persevere Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/persevere-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated